Key result
Pharmacist-led EHR medication reviews linked to ~64% provider implementation of recommended interventions at 12 months.
Why the study?
The study was conducted to evaluate the impact of pharmacist intervention on annual comprehensive medication review for Medicare Part D beneficiaries using a new technological electronic health record tool.
Does pharmacist intervention using a web-based EHR program improve the implementation of medication recommendations in Medicare Part D beneficiaries?
Observational (n=163)
Does pharmacist intervention using a web-based EHR program improve the implementation of medication recommendations in Medicare Part D beneficiaries?
p-value: p=<.05
A web-based EHR system effectively assists pharmacists in conducting comprehensive medication reviews and increasing provider implementation of medication recommendations in elderly Medicare patients.
Supports pharmacist-led EHR reviews in Medicare Part D; hypothesis-generating for RCTs on clinical outcomes.
Objective:The objective of this study was to evaluate the impact of pharmacist’s intervention on annual comprehensive medication review (Annual CMR) for Medicare Part D beneficiaries. Background: To develop a new approach to assess Medicare Part D Annual CMR using a technological tool. Methods: One hundred sixty-three (163) eligible Medicare Part D beneficiaries were enrolled. By using an Electronic Health Record (EHR) Program, the pharmacist was able to assess laboratory, pharmacy, diagnosis, and patient information. A post-medication review summary was provided to the medical providers and patients which included a medication action plan. At the end of 3 months, 6 months and 12 months after the medication review, data were collected, assessed and compared. Results: The study showed that pharmacist’s interventions were recommended to seventy-four (74) enrollees which comprised of 45% of the total enrollees. It showed that at 3-month, 6-month, and 12-month intervals after the medication review, the recommended interventions acknowledged and implemented by the medical providers were 20%, 51% and 64% respectively, which showed a significant difference over a 12-month period ( P-value <.05). Different types of pharmacist’s interventions that were recommended may include to initiate, to adjust and to discontinue medication. The most common disease states that required interventions were psychiatric disorder, cardiovascular disease, pulmonary disease, gastrointestinal disease, diabetes, dyslipidemia and pain. Conclusion: The finding of this study revealed that such a web-based EHR system was a very meaningful and effective tool in assisting pharmacists to assess the proper and safe use of medication in elderly patients.
No takes yet. Share an insight, caveat, or question.
Chong et al. (2022) conducted an observational in Medicare Part D beneficiaries (n=163). Pharmacist's intervention using a Web-Based Electronic Health Record Program was evaluated on Implementation of recommended interventions by medical providers at 12 months (p=<.05). A web-based EHR program for pharmacist-led medication reviews in Medicare Part D beneficiaries resulted in 64% of recommended interventions being implemented by medical providers at 12 months (P<.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: